NCT00462748View on ClinicalTrials.gov

A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121)

PHASE3CompletedINTERVENTIONAL
Enrollment

786

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

June 30, 2008

Study Completion Date

June 30, 2008

Conditions
Hypercholesterolemia
Interventions
DRUG

ezetimibe (+) simvastatin

ezetimibe (+) simvastatin 10/40mg. once daily tablet formulation, all tablet form, taken orally, cholesterol lowering medication.

DRUG

Comparator: atorvastatin

atorvastatin 40mg. once daily tablet formulation, all tablet form, taken orally

DRUG

Comparator: rosuvastatin

rosuvastatin 10 mg. once daily tablet formulation, all tablet form, taken orally.

All Listed Sponsors
lead

Organon and Co

INDUSTRY

NCT00462748 - A Study to Determine the Number of Patients Who Reach Optimal Cholesterol Levels on Each of Three Different Treatments (0653A-121) | Biotech Hunter | Biotech Hunter